Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Microbot Medical Inc. Director's Dealing 2012

Feb 1, 2012

33819_dirs_2012-01-31_9b88337a-a6bb-4693-89c4-bc48856a25fa.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STEMCELLS INC (STEM)
CIK: 0000883975
Period of Report: 2012-01-27

Reporting Person: TSUKAMOTO ANN (EVP, Research and Development)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-01-27 Common Stock A 130000 $0.00 Acquired 198569 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2284 Indirect
Common Stock 8853 Indirect

Footnotes

F1: Restricted stock units, with 1/3 vesting on January 27, 2013, 1/3 vesting on January 27, 2014 and 1/3 vesting on January 27, 2015.

F2: Includes (1) 130,000 restricted stock units, with 43,333 vesting on each of January 27, 2013, January 27, 2014 and January 27, 2015; (2) 46,667 restricted stock units, with 23,333 vesting on each of June 1, 2012 and June 1, 2013; and (3) 4,667 restricted stock units, with 2,333 vesting on each of May 15, 2012 and May 15, 2013. Amounts reflect automatic adjustments under applicable benefit plans triggered by issuer's 1 for 10 reverse stock split.

F3: 2,284 shares held in trust as to which Dr. Tsukamoto disclaims beneficial ownership. Amounts reflect automatic adjustments triggered by issuer's 1 for 10 reverse stock split.

F4: Shares held in 401(k) account in accordance with issuer's employer-match policies.